United States · FDA National Drug Code directory
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69911-475_757ccd2f-85b7-440f-905f-b999e2d1dd4b
- Product NDC
- 69911-475
- Form
- KIT
- Composition / generic term
- ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
- Labeler
- CSL Behring Lengnau AG
- Marketing category
- BLA
- Marketing start / end (source format)
- 20160525
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (69911-475-02) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-765-83) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-485-01) · 69911-475-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →